FDA APPROVES GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS FOR EXPANDED USE IN FEVAR AND BEVAR
RegulatoryapprovedGORE® VIABAHN® VBX Balloon Expandable EndoprosthesisPositive
AI Analysis
Summary
W. L. Gore & Associates received FDA approval for the GORE VIABAHN VBX Balloon Expandable Endoprosthesis for expanded use in fenestrated and branched endovascular aortic repair, marking the first on-label bridging stent graft for both indications. Three-year clinical outcomes demonstrated safety and effectiveness.
Outcome Details
FDA approval for expanded use in fenestrated endovascular aortic repair (FEVAR) and branched endovascular aortic repair (BEVAR); first on-label bridging stent graft for both indications; three-year clinical outcomes demonstrate safety and effectiveness
Importance:8/10
Sentiment:
0.85
FDA approvalvascular surgerymedical deviceendovascular repairstent graft
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on October 14, 2026 10:28 AM